HOME
SERVICES
INDUSTRIES
PROFESSIONALS
CLIENTS
Large Volume Filers
Small Medium Enterprises
Startup
Global
Brand Leaders
RESOURCES
ABOUT
Practice Overview
Recognition
Careers
Diversity
Pro Bono Services
PCK Events
CONTACT
MyPCK
biosimilar
Filter by
Categories
Tags
Show all
Article
Confusion
Contract
Copyright
Corporate
Domain Names
Employment
Expungement
Expungement
Grey Marketing
Industrial Designs
Licensing
Obviousness
Opposition
Passing Off
Patent
Patent Infringement
Patent Strategy
PM(NOC)
Procedure
Prosecution
recognition
Services
Summary
Trade Secrets
Trade-mark
Use
Validity
2019
35 US Code §101
3D printing
6.08
Abandonment
abstract
abstract theorems
accounting of profits
acquired distinctiveness
actions
actual notice
agreement
agreements
airport security
Alice/Mayo Test
Ambiguity
Amending
amendment
Amendments
annual maintenance fee
Anticipation
Appeal
application
application chain
application fee
arbitrary
arbitration
Assignment
Australia
Bad Faith
bill
Bill C-31
Bill C-43
Bill C-8
Bill C-86
biologics
biosimilar
Biotech Patents
border measures
Brand
branding
broadcasting
budget
burden of proof
business
CAFC
call processing
Canada
Canada Gazette
causal link
cdrp
CEEO
Certificate of Supplementary Protection
champerty
Chemical Patent
chemistry
ciba
CIPO
CIPO errors
CIRA
Claim Construction
Class Actions
clerical error
college of agents
combination
combination drugs
commissioner
Common General Knowledge
Complete Code
confidential
Confidential Information
confidentiality
confidentiality order
Conflict of Interest
confusing
confusingly similar
confusion
constitution
constitutional
constitutionality
consumer goods
contract
contributory infringement
Copyright
Copyright Infringement
copyright test
corrections
Costs
counterfeit
CSP
cybersecurity
Damages
Data
Data Protection
deadline
deadlines
defamation
defences
delay to market entry
delayed market entry
descriptive
Design Patents
deviation
digital infringement
disclosure
distinctive
distinctive feature
distinctiveness
Diversity
division of powers
divisionals
DNA Patents
domain
domain names
dominant feature
dosage range
Double Patenting
doubtful cases
due care
E-Commerce
Early dismissal
economics
errors
essentiality of elements
Ethics
Europe
Events
Evidence
examination quality
examination statistics
Examiner
expert
expert blinding
expert evidence
Experts
expiry
Expungement
extraterritoriality
federal circuit
Federal Court
Federal Court of Appeal
fee
fees
file wrapper
Filing
filing date
filing fee
financial services
foreign issue estoppel
forum selection
fraud
Free World Trust
frivolous
funding
future infringement
generics
geographical indications
global
Good Faith
goods
Google
Government
grace period
grey marketing
Hague
hearsay
hearsay evidence
Honest Contractual Performance
ICSID
Illegality
Improver
imunity
Indefiniteness
Inducement
Industrial Designs
inherent distinctiveness
injunction
Injunctions
Innovation
insufficiency
insufficient disclosure
Intellectual Property
intent
Inter Partes Review
interlocutory injunction
Internet
intra vires
invalidated
invalidation
inventor removal
inventorship
IP Lawyer
IP management
ip regime
IP Strategy
IPIC
IPO
ISP
IT patent
ITC
Jurisdiction
Late fee
Legal Retainer
legal test
legislative reform
legitimate interest
Licensing
life science
limitation periods
Litigation
litigation evidence
litigation funding agreement
madrid
maintenance
material facts
materiality
method
Methods of Medical Treatment
minister of health
misleading
monopoly
motion
Motion to dismiss
Motion to strike
NAFTA
national phase entry
new act
new evidence
no chance of success
Non-Infringing Alternative
notice of allegation
notice to rectify
novelty
obivous error
Obviousness
Office
official mark
official marks
on-sale
on-sale bar
Online
ontario
opposition
outsourcing
Overbreadth
overlapping
ownership
Ownership & Inventorship
PAB
Passing Off
patent abandonment
Patent Act
patent agent
Patent Agents
Patent and Trademark Appeal Board
patent appeal board
Patent Application
Patent Drafting
Patent Infringement
Patent Litigation
Patent Office
patent office errors
patent owner
patent ownership
patent practicioner
patent prosecution
patent protection
patent requirement
Patent Rules
Patent Strategy
patent term adjustment
Patent Textbook
Patent Trolls
patentability
Patentable Subject Matter
Patents
PCT
Pharmaceutical Patent
Pharmaceutical Pricing
PLT
PM(NOC)
PM(NOC) Damages
PMPRB
POSITA
price regulation
pride
prior art
prior disclosure
prior disclosure defence
prior use
priority
priority claim
priority claims
priority date
Privilege
procedure
Product Specificity
profit
prohibited marks
Promise Doctrine
proprietor
Prosecution
protective order
prothonotaries
Provisional Patent
public sale
Public Servant
Punitive Damages
Recognition
Records
registration
reinstatement
relevant date for construction
Remedies
representation
request for correction
requisition
responding
review
risk
Royalties
s. 27
s. 45
s. 53
sale
Scheduling
SCOTUS
second person
Secondary Infringement
secondary meaning
secret sale
section 28
Section 45
section 50
Section 52
section 56
section 7
security
selection patents
Services
settlement
skilled person
software
Software Copyright
Software Patent
software patents
Sound Prediction
specification
sponsorship
SRED
Standard of Review
standing
standing to appeal
Start-up
Startups
statute of monopolies
stay
Strategy
Sufficiency
Summary Judgment
summary trial
superior court
Supreme Court of Canada
surname
Technology
test
third party
time frame
top patent agent
TPP
Trade Secrets
Trade-Mark
trade-marks act
Trademark
Trademark Act
trademark agent
Trademark Infringement
trademark opposition
treaty
UK
united kingdom
United States
unpatentable
untrue material allegation
Use
useful article
USMCA
USPTO
Utility
Validity
variant
Varying records
Velocity
vexatious
who's who legal
admin
administrator
Caroline Henrie
Damian Rolfe
Gillian Burrell
PCK
PCK-Reporter
Monica
Wendy Low
April 4, 2019
April 4, 2019
Actions Under Old PM(NOC) Regime Not Automatically Applicable To The New
2018 FC 1078 - Canada's Federal Court confirms that jurisprudence under previous PM(NOC) regime is not automatically applicable to the new.
